Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
(1,2,6,7‑3H)Testosterone is a radiolabeled form of testosterone in which tritium (^3H), a radioactive isotope of hydrogen used as a tracer in biochemical research and autoradiography studies[1][2][4]. This compound is chemically identical to endogenous testosterone except for the presence of tritium atoms at positions 1-, 2-, 6-, and 7-. It is primarily used as an experimental tool to study testosterone metabolism and androgen receptor binding in tissues. The radiolabel allows sensitive detection and quantification of testosterone uptake and conversion by various cells or tissues. Its mechanism of action mirrors that of natural testosterone—agonism at the androgen receptor—though its primary use is not therapeutic but investigative[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1,2,6,7-3H)Testosterone.